샘플 요청 목록

 카트 문의
시장보고서
상품코드
1786000

임상시험 매칭 소프트웨어 시장

Clinical Trials Matching Software
발행일: | 리서치사: Market Glass, Inc. (Formerly Global Industry Analysts, Inc.) | 페이지 정보: 영문 276 Pages | 배송안내 : 1-2일 (영업일 기준)

    
    
    



※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

세계의 임상시험 매칭 소프트웨어 시장은 2030년까지 3억 7,950만 달러에 달할 전망

2024년에 1억 8,710만 달러로 추정되는 세계의 임상시험 매칭 소프트웨어 시장은 2030년에는 3억 7,950만 달러에 달하며, 분석 기간인 2024-2030년 CAGR은 12.5%로 성장할 것으로 예측됩니다. 이 리포트에서 분석한 부문의 하나인 웹 및 클라우드 기반 배포는 CAGR 14.7%를 기록하며, 분석 기간 종료시에는 2억 4,780만 달러에 달할 것으로 예측됩니다. 온프레미스 배포 부문의 성장률은 분석 기간 중 CAGR 9.1%로 추정됩니다.

미국 시장은 5,100만 달러로 추정, 중국은 CAGR 17.2%로 성장 예측

미국의 임상시험 매칭 소프트웨어 시장은 2024년에 5,100만 달러로 추정됩니다. 세계 2위의 경제대국인 중국은 2030년까지 8,140만 달러의 시장 규모에 달할 것으로 예측되며, 분석 기간인 2024-2030년 CAGR은 17.2%입니다. 기타 주목할 만한 지역별 시장으로는 일본과 캐나다가 있으며, 분석 기간 중 CAGR은 각각 8.9%와 11.3%로 예측됩니다. 유럽에서는 독일이 CAGR 약 9.9%로 성장할 것으로 예측됩니다.

세계의 임상시험 매칭 소프트웨어 시장 - 주요 동향과 촉진요인 정리

임상시험 매칭 소프트웨어가 환자 등록을 변화시키는 이유는 무엇인가?

임상시험 매칭 소프트웨어는 인공지능(AI)과 빅데이터 분석을 활용하여 적격 참가자와 관련 임상시험을 연결함으로써 환자 모집에 혁명을 일으키고 있습니다. 기존의 환자 등록 방법은 비효율적인 경우가 많으며, 그 결과 임상시험 일정이 지연되거나 탈락률이 높아지는 경우가 많습니다. 매칭 소프트웨어는 전자의무기록(EHR), 유전자 데이터, 환자 보고 결과를 분석하여 적합한 후보자를 실시간으로 식별함으로써 이러한 문제를 해결합니다. 이 기술은 환자 수가 제한되어 있으며, 적격 환자를 찾기가 어려운 희귀질환 임상시험에 특히 유용합니다. 또한 환자 중심의 임상시험이 증가함에 따라 자동 매칭 솔루션의 채택이 증가하고 있으며, 환자별 의료 프로파일을 기반으로 한 혁신적인 치료법에 대한 접근성이 향상되고 있습니다.

첨단 임상시험 매칭 소프트웨어의 주요 특징은 무엇인가?

최신 임상시험 매칭 소프트웨어는 첨단 알고리즘, 자연 언어 처리(NLP), AI 기반 분석을 통해 환자 식별 및 등록을 효율화합니다. 클라우드 기반 플랫폼은 병원 데이터베이스와의 원활한 통합을 용이하게 하고, 임상시험 자격 기준을 실시간으로 업데이트할 수 있도록 합니다. 환자 참여형 포털과 모바일 애플리케이션는 환자가 자신의 상태, 위치, 치료 선호도에 따라 관련 임상시험을 검색할 수 있도록 함으로써 환자 모집을 더욱 강화할 수 있습니다. 또한 블록체인 기술을 도입하여 데이터 프라이버시와 보안을 개선하고, 디지털 매칭 플랫폼에 대한 환자의 신뢰를 확보하기 위해 블록체인 기술을 도입했습니다. AI와 예측 모델링이 계속 발전함에 따라 임상시험 매칭 소프트웨어의 정확도가 점점 더 높아져 스크리닝 실패를 최소화하고 전체 임상시험의 효율성을 향상시키고 있습니다.

매칭 소프트웨어가 임상시험의 다양성과 포용성을 어떻게 개선하고 있는가?

임상연구의 가장 큰 과제 중 하나는 임상시험 집단의 다양한 대표성을 확보하는 것입니다. 매칭 소프트웨어는 아웃리치 활동을 확장하고, 충분히 대표되지 않은 계층에서 자격을 갖춘 참가자를 식별함으로써 이 문제를 해결하고 있습니다. AI 기반 분석은 건강의 사회적 결정 요인을 파악하는 데 도움이 되며, 인종적, 지역적, 경제적 요인을 고려한 타겟팅된 채택 전략을 가능하게 합니다. 소프트웨어 프로바이더, 옹호 단체, 지역 의료 센터 간의 파트너십을 통해 임상시험 기회에 대한 공평한 접근을 더욱 보장하고 있습니다. 임상시험 등록의 격차를 줄임으로써 매칭 소프트웨어는 건강 형평성을 증진하고 임상 연구 결과의 일반화 가능성을 향상시키는 데 중요한 역할을 하고 있습니다.

임상시험 매칭 소프트웨어 시장의 성장 원동력은?

임상시험 매칭 소프트웨어 시장의 성장은 효율적인 환자 모집에 대한 수요 증가, AI 기반 분석의 발전, 분산형 임상시험의 확대 등 몇 가지 요인에 기인합니다. 임상시험 일정을 단축해야 하는 제약사들은 지연을 최소화할 수 있는 자동 등록 솔루션에 대한 투자를 늘리고 있습니다. 규제 당국도 임상시험의 다양성 확대를 옹호하고 있으며, 환자 타겟팅을 촉진하는 소프트웨어의 채택을 장려하고 있습니다. 또한 환자를 직접 모집하는 모델의 부상으로 모바일 친화적인 매칭 플랫폼에 대한 수요가 증가하고 있습니다. 정밀의료가 지속적으로 확산됨에 따라 AI를 활용한 매칭 솔루션의 활용이 확대되고, 시장 성장이 더욱 가속화될 것으로 예측됩니다.

부문

배포(웹 및 클라우드 기반 배포, 온프레미스 배포), 최종사용자(제약 및 바이오테크놀러지 기업 최종사용자, CRO 최종사용자, 의료기기 기업 최종사용자)

조사 대상 기업의 예

  • Adaptive Clinical Systems
  • Antidote Technologies
  • AutoCruitment
  • BBK Worldwide
  • Clariness
  • Clario
  • ClinicalConnection
  • ClinOne
  • CSSi
  • Deep 6 AI
  • Greenphire
  • H1 Inc.
  • IBM Watson Health
  • Medidata Solutions
  • Neuro-Behavioral Clinical Research Inc.
  • Parexel International Corporation
  • PRA Health Sciences
  • Syneos Health
  • Tandem Clinical Research
  • TriNetX

AI 통합

Global Industry Analysts는 유효한 전문가 컨텐츠와 AI 툴에 의해 시장 정보와 경쟁 정보를 변혁하고 있습니다.

Global Industry Analysts는 일반적인 LLM나 업계별 SLM 쿼리에 따르는 대신에, 비디오 기록, 블로그, 검색 엔진 조사, 대량 기업, 제품/서비스, 시장 데이터 등, 전 세계 전문가로부터 수집한 컨텐츠 리포지토리를 구축했습니다.

관세 영향 계수

Global Industry Analysts는 본사 소재지, 제조거점, 수출입(완제품 및 OEM)을 기준으로 기업의 경쟁력 변화를 예측했습니다. 이러한 복잡하고 다면적인 시장 역학은 수입원가(COGS) 증가, 수익성 하락, 공급망 재편 등 미시적, 거시적 시장 역학 중에서도 특히 경쟁사들에게 영향을 미칠 것으로 예측됩니다.

목차

제1장 조사 방법

제2장 개요

  • 시장 개요
  • 주요 기업
  • 시장 동향과 촉진요인
  • 세계 시장 전망

제3장 시장 분석

  • 미국
  • 캐나다
  • 일본
  • 중국
  • 유럽
  • 프랑스
  • 독일
  • 이탈리아
  • 영국
  • 스페인
  • 러시아
  • 기타 유럽
  • 아시아태평양
  • 호주
  • 인도
  • 한국
  • 기타 아시아태평양
  • 라틴아메리카
  • 아르헨티나
  • 브라질
  • 멕시코
  • 기타 라틴아메리카
  • 중동
  • 이란
  • 이스라엘
  • 사우디아라비아
  • 아랍에미리트
  • 기타 중동
  • 아프리카

제4장 경쟁

KSA 25.08.19

Global Clinical Trials Matching Software Market to Reach US$379.5 Million by 2030

The global market for Clinical Trials Matching Software estimated at US$187.1 Million in the year 2024, is expected to reach US$379.5 Million by 2030, growing at a CAGR of 12.5% over the analysis period 2024-2030. Web & Cloud-based Deployment, one of the segments analyzed in the report, is expected to record a 14.7% CAGR and reach US$247.8 Million by the end of the analysis period. Growth in the On-Premise Deployment segment is estimated at 9.1% CAGR over the analysis period.

The U.S. Market is Estimated at US$51.0 Million While China is Forecast to Grow at 17.2% CAGR

The Clinical Trials Matching Software market in the U.S. is estimated at US$51.0 Million in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$81.4 Million by the year 2030 trailing a CAGR of 17.2% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 8.9% and 11.3% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 9.9% CAGR.

Global Clinical Trials Matching Software Market - Key Trends & Drivers Summarized

Why Is Clinical Trials Matching Software Transforming Patient Enrollment?

Clinical trials matching software is revolutionizing patient recruitment by leveraging artificial intelligence (AI) and big data analytics to connect eligible participants with relevant clinical studies. Traditional patient enrollment methods often suffer from inefficiencies, resulting in delayed trial timelines and high dropout rates. Matching software addresses these challenges by analyzing electronic health records (EHRs), genetic data, and patient-reported outcomes to identify suitable candidates in real time. This technology is particularly beneficial for rare disease trials, where finding eligible participants is often difficult due to limited patient populations. Additionally, the rise of patient-centric trials is increasing the adoption of automated matching solutions, ensuring that individuals have better access to innovative treatments based on their unique medical profiles.

What Are the Key Features of Advanced Trials Matching Software?

Modern clinical trials matching software incorporates advanced algorithms, natural language processing (NLP), and AI-driven analytics to streamline patient identification and enrollment. Cloud-based platforms facilitate seamless integration with hospital databases, enabling real-time updates on trial eligibility criteria. Patient engagement portals and mobile applications further enhance recruitment by allowing individuals to search for relevant trials based on their condition, location, and treatment preferences. Additionally, blockchain technology is being implemented to improve data privacy and security, ensuring patient trust in digital matching platforms. As AI and predictive modeling continue to evolve, trials matching software is becoming increasingly precise, minimizing screening failures and improving overall trial efficiency.

How Is Matching Software Improving Diversity and Inclusion in Clinical Trials?

One of the biggest challenges in clinical research is ensuring diverse representation in trial populations. Matching software is addressing this issue by expanding outreach efforts and identifying eligible participants from underrepresented demographics. AI-driven analytics help pinpoint social determinants of health, enabling targeted recruitment strategies that account for ethnic, geographic, and economic factors. Partnerships between software providers, advocacy groups, and community health centers are further ensuring equitable access to trial opportunities. By reducing disparities in trial enrollment, matching software is playing a key role in advancing health equity and improving the generalizability of clinical research findings.

What’s Driving the Growth of the Clinical Trials Matching Software Market?

The growth in the clinical trials matching software market is driven by several factors, including the increasing demand for efficient patient recruitment, advancements in AI-driven analytics, and the expansion of decentralized trials. The need for faster trial timelines is encouraging pharmaceutical companies to invest in automated enrollment solutions that minimize delays. Regulatory agencies are also advocating for greater diversity in clinical trials, driving the adoption of software that facilitates targeted patient outreach. Additionally, the rise of direct-to-patient recruitment models is fueling demand for mobile-friendly matching platforms. As precision medicine continues to gain traction, the use of AI-powered matching solutions is expected to expand, further accelerating market growth.

SCOPE OF STUDY:

The report analyzes the Clinical Trials Matching Software market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Deployment (Web and Cloud-based Deployment, On-Premise Deployment); End-Use (Pharmaceutical and Biotechnology Companies End-Use, CROs End-Use, Medical Device Firms End-Use)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Select Competitors (Total 42 Featured) -

  • Adaptive Clinical Systems
  • Antidote Technologies
  • AutoCruitment
  • BBK Worldwide
  • Clariness
  • Clario
  • ClinicalConnection
  • ClinOne
  • CSSi
  • Deep 6 AI
  • Greenphire
  • H1 Inc.
  • IBM Watson Health
  • Medidata Solutions
  • Neuro-Behavioral Clinical Research Inc.
  • Parexel International Corporation
  • PRA Health Sciences
  • Syneos Health
  • Tandem Clinical Research
  • TriNetX

AI INTEGRATIONS

We're transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • Tariff Impact on Global Supply Chain Patterns
    • Clinical Trials Matching Software - Global Key Competitors Percentage Market Share in 2025 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • AI-Powered Patient Matching Solutions Propel Growth in Clinical Trial Recruitment
    • Rising Clinical Trial Complexity Strengthens the Case for Automated Matching Platforms
    • Integration of EHR & EMR Data Enhances Accuracy & Efficiency in Trial Matching
    • Cloud-Based Clinical Trial Matching Software Expands Addressable Market Opportunity
    • Increasing Focus on Diversity & Inclusion Bodes Well for AI-Driven Matching Technologies
    • Regulatory Push for More Patient-Centric Trials Accelerates Adoption of Matching Platforms
    • Blockchain Technology Improves Transparency & Trust in Trial Matching
    • Expansion of Virtual & Decentralized Trials Drives Demand for Digital Matching Solutions
    • Growing Pharma & Biotech Investments in AI Strengthen Business Case for Trial Matching Software
    • Integration of Mobile Apps & Chatbots Enhances Patient Engagement & Trial Enrollment
    • Higher Trial Dropout Rates Propel Demand for Personalized Patient Engagement Tools
    • Predictive Analytics for Trial Feasibility & Site Selection Enhances Market Appeal
    • Growing Role of Social Media & Digital Recruitment Platforms in Patient Matching
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Clinical Trials Matching Software Market Analysis of Annual Sales in US$ for Years 2015 through 2030
    • TABLE 2: World Recent Past, Current & Future Analysis for Clinical Trials Matching Software by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
    • TABLE 3: World Historic Review for Clinical Trials Matching Software by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 4: World 15-Year Perspective for Clinical Trials Matching Software by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2015, 2025 & 2030
    • TABLE 5: World Recent Past, Current & Future Analysis for Web & Cloud-based Deployment by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
    • TABLE 6: World Historic Review for Web & Cloud-based Deployment by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 7: World 15-Year Perspective for Web & Cloud-based Deployment by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 8: World Recent Past, Current & Future Analysis for On-Premise Deployment by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
    • TABLE 9: World Historic Review for On-Premise Deployment by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 10: World 15-Year Perspective for On-Premise Deployment by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 11: World Recent Past, Current & Future Analysis for Pharmaceutical & Biotechnology Companies End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
    • TABLE 12: World Historic Review for Pharmaceutical & Biotechnology Companies End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 13: World 15-Year Perspective for Pharmaceutical & Biotechnology Companies End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 14: World Recent Past, Current & Future Analysis for CROs End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
    • TABLE 15: World Historic Review for CROs End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 16: World 15-Year Perspective for CROs End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 17: World Recent Past, Current & Future Analysis for Medical Device Firms End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
    • TABLE 18: World Historic Review for Medical Device Firms End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 19: World 15-Year Perspective for Medical Device Firms End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Clinical Trials Matching Software Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
    • TABLE 20: USA Recent Past, Current & Future Analysis for Clinical Trials Matching Software by Deployment - Web & Cloud-based Deployment and On-Premise Deployment - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 21: USA Historic Review for Clinical Trials Matching Software by Deployment - Web & Cloud-based Deployment and On-Premise Deployment Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 22: USA 15-Year Perspective for Clinical Trials Matching Software by Deployment - Percentage Breakdown of Value Sales for Web & Cloud-based Deployment and On-Premise Deployment for the Years 2015, 2025 & 2030
    • TABLE 23: USA Recent Past, Current & Future Analysis for Clinical Trials Matching Software by End-Use - Pharmaceutical & Biotechnology Companies End-Use, CROs End-Use and Medical Device Firms End-Use - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 24: USA Historic Review for Clinical Trials Matching Software by End-Use - Pharmaceutical & Biotechnology Companies End-Use, CROs End-Use and Medical Device Firms End-Use Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 25: USA 15-Year Perspective for Clinical Trials Matching Software by End-Use - Percentage Breakdown of Value Sales for Pharmaceutical & Biotechnology Companies End-Use, CROs End-Use and Medical Device Firms End-Use for the Years 2015, 2025 & 2030
  • CANADA
    • TABLE 26: Canada Recent Past, Current & Future Analysis for Clinical Trials Matching Software by Deployment - Web & Cloud-based Deployment and On-Premise Deployment - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 27: Canada Historic Review for Clinical Trials Matching Software by Deployment - Web & Cloud-based Deployment and On-Premise Deployment Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 28: Canada 15-Year Perspective for Clinical Trials Matching Software by Deployment - Percentage Breakdown of Value Sales for Web & Cloud-based Deployment and On-Premise Deployment for the Years 2015, 2025 & 2030
    • TABLE 29: Canada Recent Past, Current & Future Analysis for Clinical Trials Matching Software by End-Use - Pharmaceutical & Biotechnology Companies End-Use, CROs End-Use and Medical Device Firms End-Use - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 30: Canada Historic Review for Clinical Trials Matching Software by End-Use - Pharmaceutical & Biotechnology Companies End-Use, CROs End-Use and Medical Device Firms End-Use Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 31: Canada 15-Year Perspective for Clinical Trials Matching Software by End-Use - Percentage Breakdown of Value Sales for Pharmaceutical & Biotechnology Companies End-Use, CROs End-Use and Medical Device Firms End-Use for the Years 2015, 2025 & 2030
  • JAPAN
    • Clinical Trials Matching Software Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
    • TABLE 32: Japan Recent Past, Current & Future Analysis for Clinical Trials Matching Software by Deployment - Web & Cloud-based Deployment and On-Premise Deployment - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 33: Japan Historic Review for Clinical Trials Matching Software by Deployment - Web & Cloud-based Deployment and On-Premise Deployment Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 34: Japan 15-Year Perspective for Clinical Trials Matching Software by Deployment - Percentage Breakdown of Value Sales for Web & Cloud-based Deployment and On-Premise Deployment for the Years 2015, 2025 & 2030
    • TABLE 35: Japan Recent Past, Current & Future Analysis for Clinical Trials Matching Software by End-Use - Pharmaceutical & Biotechnology Companies End-Use, CROs End-Use and Medical Device Firms End-Use - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 36: Japan Historic Review for Clinical Trials Matching Software by End-Use - Pharmaceutical & Biotechnology Companies End-Use, CROs End-Use and Medical Device Firms End-Use Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 37: Japan 15-Year Perspective for Clinical Trials Matching Software by End-Use - Percentage Breakdown of Value Sales for Pharmaceutical & Biotechnology Companies End-Use, CROs End-Use and Medical Device Firms End-Use for the Years 2015, 2025 & 2030
  • CHINA
    • Clinical Trials Matching Software Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
    • TABLE 38: China Recent Past, Current & Future Analysis for Clinical Trials Matching Software by Deployment - Web & Cloud-based Deployment and On-Premise Deployment - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 39: China Historic Review for Clinical Trials Matching Software by Deployment - Web & Cloud-based Deployment and On-Premise Deployment Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 40: China 15-Year Perspective for Clinical Trials Matching Software by Deployment - Percentage Breakdown of Value Sales for Web & Cloud-based Deployment and On-Premise Deployment for the Years 2015, 2025 & 2030
    • TABLE 41: China Recent Past, Current & Future Analysis for Clinical Trials Matching Software by End-Use - Pharmaceutical & Biotechnology Companies End-Use, CROs End-Use and Medical Device Firms End-Use - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 42: China Historic Review for Clinical Trials Matching Software by End-Use - Pharmaceutical & Biotechnology Companies End-Use, CROs End-Use and Medical Device Firms End-Use Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 43: China 15-Year Perspective for Clinical Trials Matching Software by End-Use - Percentage Breakdown of Value Sales for Pharmaceutical & Biotechnology Companies End-Use, CROs End-Use and Medical Device Firms End-Use for the Years 2015, 2025 & 2030
  • EUROPE
    • Clinical Trials Matching Software Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
    • TABLE 44: Europe Recent Past, Current & Future Analysis for Clinical Trials Matching Software by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
    • TABLE 45: Europe Historic Review for Clinical Trials Matching Software by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 46: Europe 15-Year Perspective for Clinical Trials Matching Software by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2015, 2025 & 2030
    • TABLE 47: Europe Recent Past, Current & Future Analysis for Clinical Trials Matching Software by Deployment - Web & Cloud-based Deployment and On-Premise Deployment - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 48: Europe Historic Review for Clinical Trials Matching Software by Deployment - Web & Cloud-based Deployment and On-Premise Deployment Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 49: Europe 15-Year Perspective for Clinical Trials Matching Software by Deployment - Percentage Breakdown of Value Sales for Web & Cloud-based Deployment and On-Premise Deployment for the Years 2015, 2025 & 2030
    • TABLE 50: Europe Recent Past, Current & Future Analysis for Clinical Trials Matching Software by End-Use - Pharmaceutical & Biotechnology Companies End-Use, CROs End-Use and Medical Device Firms End-Use - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 51: Europe Historic Review for Clinical Trials Matching Software by End-Use - Pharmaceutical & Biotechnology Companies End-Use, CROs End-Use and Medical Device Firms End-Use Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 52: Europe 15-Year Perspective for Clinical Trials Matching Software by End-Use - Percentage Breakdown of Value Sales for Pharmaceutical & Biotechnology Companies End-Use, CROs End-Use and Medical Device Firms End-Use for the Years 2015, 2025 & 2030
  • FRANCE
    • Clinical Trials Matching Software Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
    • TABLE 53: France Recent Past, Current & Future Analysis for Clinical Trials Matching Software by Deployment - Web & Cloud-based Deployment and On-Premise Deployment - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 54: France Historic Review for Clinical Trials Matching Software by Deployment - Web & Cloud-based Deployment and On-Premise Deployment Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 55: France 15-Year Perspective for Clinical Trials Matching Software by Deployment - Percentage Breakdown of Value Sales for Web & Cloud-based Deployment and On-Premise Deployment for the Years 2015, 2025 & 2030
    • TABLE 56: France Recent Past, Current & Future Analysis for Clinical Trials Matching Software by End-Use - Pharmaceutical & Biotechnology Companies End-Use, CROs End-Use and Medical Device Firms End-Use - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 57: France Historic Review for Clinical Trials Matching Software by End-Use - Pharmaceutical & Biotechnology Companies End-Use, CROs End-Use and Medical Device Firms End-Use Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 58: France 15-Year Perspective for Clinical Trials Matching Software by End-Use - Percentage Breakdown of Value Sales for Pharmaceutical & Biotechnology Companies End-Use, CROs End-Use and Medical Device Firms End-Use for the Years 2015, 2025 & 2030
  • GERMANY
    • Clinical Trials Matching Software Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
    • TABLE 59: Germany Recent Past, Current & Future Analysis for Clinical Trials Matching Software by Deployment - Web & Cloud-based Deployment and On-Premise Deployment - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 60: Germany Historic Review for Clinical Trials Matching Software by Deployment - Web & Cloud-based Deployment and On-Premise Deployment Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 61: Germany 15-Year Perspective for Clinical Trials Matching Software by Deployment - Percentage Breakdown of Value Sales for Web & Cloud-based Deployment and On-Premise Deployment for the Years 2015, 2025 & 2030
    • TABLE 62: Germany Recent Past, Current & Future Analysis for Clinical Trials Matching Software by End-Use - Pharmaceutical & Biotechnology Companies End-Use, CROs End-Use and Medical Device Firms End-Use - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 63: Germany Historic Review for Clinical Trials Matching Software by End-Use - Pharmaceutical & Biotechnology Companies End-Use, CROs End-Use and Medical Device Firms End-Use Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 64: Germany 15-Year Perspective for Clinical Trials Matching Software by End-Use - Percentage Breakdown of Value Sales for Pharmaceutical & Biotechnology Companies End-Use, CROs End-Use and Medical Device Firms End-Use for the Years 2015, 2025 & 2030
  • ITALY
    • TABLE 65: Italy Recent Past, Current & Future Analysis for Clinical Trials Matching Software by Deployment - Web & Cloud-based Deployment and On-Premise Deployment - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 66: Italy Historic Review for Clinical Trials Matching Software by Deployment - Web & Cloud-based Deployment and On-Premise Deployment Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 67: Italy 15-Year Perspective for Clinical Trials Matching Software by Deployment - Percentage Breakdown of Value Sales for Web & Cloud-based Deployment and On-Premise Deployment for the Years 2015, 2025 & 2030
    • TABLE 68: Italy Recent Past, Current & Future Analysis for Clinical Trials Matching Software by End-Use - Pharmaceutical & Biotechnology Companies End-Use, CROs End-Use and Medical Device Firms End-Use - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 69: Italy Historic Review for Clinical Trials Matching Software by End-Use - Pharmaceutical & Biotechnology Companies End-Use, CROs End-Use and Medical Device Firms End-Use Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 70: Italy 15-Year Perspective for Clinical Trials Matching Software by End-Use - Percentage Breakdown of Value Sales for Pharmaceutical & Biotechnology Companies End-Use, CROs End-Use and Medical Device Firms End-Use for the Years 2015, 2025 & 2030
  • UNITED KINGDOM
    • Clinical Trials Matching Software Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
    • TABLE 71: UK Recent Past, Current & Future Analysis for Clinical Trials Matching Software by Deployment - Web & Cloud-based Deployment and On-Premise Deployment - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 72: UK Historic Review for Clinical Trials Matching Software by Deployment - Web & Cloud-based Deployment and On-Premise Deployment Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 73: UK 15-Year Perspective for Clinical Trials Matching Software by Deployment - Percentage Breakdown of Value Sales for Web & Cloud-based Deployment and On-Premise Deployment for the Years 2015, 2025 & 2030
    • TABLE 74: UK Recent Past, Current & Future Analysis for Clinical Trials Matching Software by End-Use - Pharmaceutical & Biotechnology Companies End-Use, CROs End-Use and Medical Device Firms End-Use - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 75: UK Historic Review for Clinical Trials Matching Software by End-Use - Pharmaceutical & Biotechnology Companies End-Use, CROs End-Use and Medical Device Firms End-Use Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 76: UK 15-Year Perspective for Clinical Trials Matching Software by End-Use - Percentage Breakdown of Value Sales for Pharmaceutical & Biotechnology Companies End-Use, CROs End-Use and Medical Device Firms End-Use for the Years 2015, 2025 & 2030
  • SPAIN
    • TABLE 77: Spain Recent Past, Current & Future Analysis for Clinical Trials Matching Software by Deployment - Web & Cloud-based Deployment and On-Premise Deployment - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 78: Spain Historic Review for Clinical Trials Matching Software by Deployment - Web & Cloud-based Deployment and On-Premise Deployment Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 79: Spain 15-Year Perspective for Clinical Trials Matching Software by Deployment - Percentage Breakdown of Value Sales for Web & Cloud-based Deployment and On-Premise Deployment for the Years 2015, 2025 & 2030
    • TABLE 80: Spain Recent Past, Current & Future Analysis for Clinical Trials Matching Software by End-Use - Pharmaceutical & Biotechnology Companies End-Use, CROs End-Use and Medical Device Firms End-Use - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 81: Spain Historic Review for Clinical Trials Matching Software by End-Use - Pharmaceutical & Biotechnology Companies End-Use, CROs End-Use and Medical Device Firms End-Use Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 82: Spain 15-Year Perspective for Clinical Trials Matching Software by End-Use - Percentage Breakdown of Value Sales for Pharmaceutical & Biotechnology Companies End-Use, CROs End-Use and Medical Device Firms End-Use for the Years 2015, 2025 & 2030
  • RUSSIA
    • TABLE 83: Russia Recent Past, Current & Future Analysis for Clinical Trials Matching Software by Deployment - Web & Cloud-based Deployment and On-Premise Deployment - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 84: Russia Historic Review for Clinical Trials Matching Software by Deployment - Web & Cloud-based Deployment and On-Premise Deployment Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 85: Russia 15-Year Perspective for Clinical Trials Matching Software by Deployment - Percentage Breakdown of Value Sales for Web & Cloud-based Deployment and On-Premise Deployment for the Years 2015, 2025 & 2030
    • TABLE 86: Russia Recent Past, Current & Future Analysis for Clinical Trials Matching Software by End-Use - Pharmaceutical & Biotechnology Companies End-Use, CROs End-Use and Medical Device Firms End-Use - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 87: Russia Historic Review for Clinical Trials Matching Software by End-Use - Pharmaceutical & Biotechnology Companies End-Use, CROs End-Use and Medical Device Firms End-Use Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 88: Russia 15-Year Perspective for Clinical Trials Matching Software by End-Use - Percentage Breakdown of Value Sales for Pharmaceutical & Biotechnology Companies End-Use, CROs End-Use and Medical Device Firms End-Use for the Years 2015, 2025 & 2030
  • REST OF EUROPE
    • TABLE 89: Rest of Europe Recent Past, Current & Future Analysis for Clinical Trials Matching Software by Deployment - Web & Cloud-based Deployment and On-Premise Deployment - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 90: Rest of Europe Historic Review for Clinical Trials Matching Software by Deployment - Web & Cloud-based Deployment and On-Premise Deployment Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 91: Rest of Europe 15-Year Perspective for Clinical Trials Matching Software by Deployment - Percentage Breakdown of Value Sales for Web & Cloud-based Deployment and On-Premise Deployment for the Years 2015, 2025 & 2030
    • TABLE 92: Rest of Europe Recent Past, Current & Future Analysis for Clinical Trials Matching Software by End-Use - Pharmaceutical & Biotechnology Companies End-Use, CROs End-Use and Medical Device Firms End-Use - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 93: Rest of Europe Historic Review for Clinical Trials Matching Software by End-Use - Pharmaceutical & Biotechnology Companies End-Use, CROs End-Use and Medical Device Firms End-Use Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 94: Rest of Europe 15-Year Perspective for Clinical Trials Matching Software by End-Use - Percentage Breakdown of Value Sales for Pharmaceutical & Biotechnology Companies End-Use, CROs End-Use and Medical Device Firms End-Use for the Years 2015, 2025 & 2030
  • ASIA-PACIFIC
    • Clinical Trials Matching Software Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
    • TABLE 95: Asia-Pacific Recent Past, Current & Future Analysis for Clinical Trials Matching Software by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
    • TABLE 96: Asia-Pacific Historic Review for Clinical Trials Matching Software by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 97: Asia-Pacific 15-Year Perspective for Clinical Trials Matching Software by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2015, 2025 & 2030
    • TABLE 98: Asia-Pacific Recent Past, Current & Future Analysis for Clinical Trials Matching Software by Deployment - Web & Cloud-based Deployment and On-Premise Deployment - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 99: Asia-Pacific Historic Review for Clinical Trials Matching Software by Deployment - Web & Cloud-based Deployment and On-Premise Deployment Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 100: Asia-Pacific 15-Year Perspective for Clinical Trials Matching Software by Deployment - Percentage Breakdown of Value Sales for Web & Cloud-based Deployment and On-Premise Deployment for the Years 2015, 2025 & 2030
    • TABLE 101: Asia-Pacific Recent Past, Current & Future Analysis for Clinical Trials Matching Software by End-Use - Pharmaceutical & Biotechnology Companies End-Use, CROs End-Use and Medical Device Firms End-Use - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 102: Asia-Pacific Historic Review for Clinical Trials Matching Software by End-Use - Pharmaceutical & Biotechnology Companies End-Use, CROs End-Use and Medical Device Firms End-Use Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 103: Asia-Pacific 15-Year Perspective for Clinical Trials Matching Software by End-Use - Percentage Breakdown of Value Sales for Pharmaceutical & Biotechnology Companies End-Use, CROs End-Use and Medical Device Firms End-Use for the Years 2015, 2025 & 2030
  • AUSTRALIA
    • Clinical Trials Matching Software Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2025 (E)
    • TABLE 104: Australia Recent Past, Current & Future Analysis for Clinical Trials Matching Software by Deployment - Web & Cloud-based Deployment and On-Premise Deployment - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 105: Australia Historic Review for Clinical Trials Matching Software by Deployment - Web & Cloud-based Deployment and On-Premise Deployment Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 106: Australia 15-Year Perspective for Clinical Trials Matching Software by Deployment - Percentage Breakdown of Value Sales for Web & Cloud-based Deployment and On-Premise Deployment for the Years 2015, 2025 & 2030
    • TABLE 107: Australia Recent Past, Current & Future Analysis for Clinical Trials Matching Software by End-Use - Pharmaceutical & Biotechnology Companies End-Use, CROs End-Use and Medical Device Firms End-Use - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 108: Australia Historic Review for Clinical Trials Matching Software by End-Use - Pharmaceutical & Biotechnology Companies End-Use, CROs End-Use and Medical Device Firms End-Use Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 109: Australia 15-Year Perspective for Clinical Trials Matching Software by End-Use - Percentage Breakdown of Value Sales for Pharmaceutical & Biotechnology Companies End-Use, CROs End-Use and Medical Device Firms End-Use for the Years 2015, 2025 & 2030
  • INDIA
    • Clinical Trials Matching Software Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2025 (E)
    • TABLE 110: India Recent Past, Current & Future Analysis for Clinical Trials Matching Software by Deployment - Web & Cloud-based Deployment and On-Premise Deployment - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 111: India Historic Review for Clinical Trials Matching Software by Deployment - Web & Cloud-based Deployment and On-Premise Deployment Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 112: India 15-Year Perspective for Clinical Trials Matching Software by Deployment - Percentage Breakdown of Value Sales for Web & Cloud-based Deployment and On-Premise Deployment for the Years 2015, 2025 & 2030
    • TABLE 113: India Recent Past, Current & Future Analysis for Clinical Trials Matching Software by End-Use - Pharmaceutical & Biotechnology Companies End-Use, CROs End-Use and Medical Device Firms End-Use - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 114: India Historic Review for Clinical Trials Matching Software by End-Use - Pharmaceutical & Biotechnology Companies End-Use, CROs End-Use and Medical Device Firms End-Use Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 115: India 15-Year Perspective for Clinical Trials Matching Software by End-Use - Percentage Breakdown of Value Sales for Pharmaceutical & Biotechnology Companies End-Use, CROs End-Use and Medical Device Firms End-Use for the Years 2015, 2025 & 2030
  • SOUTH KOREA
    • TABLE 116: South Korea Recent Past, Current & Future Analysis for Clinical Trials Matching Software by Deployment - Web & Cloud-based Deployment and On-Premise Deployment - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 117: South Korea Historic Review for Clinical Trials Matching Software by Deployment - Web & Cloud-based Deployment and On-Premise Deployment Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 118: South Korea 15-Year Perspective for Clinical Trials Matching Software by Deployment - Percentage Breakdown of Value Sales for Web & Cloud-based Deployment and On-Premise Deployment for the Years 2015, 2025 & 2030
    • TABLE 119: South Korea Recent Past, Current & Future Analysis for Clinical Trials Matching Software by End-Use - Pharmaceutical & Biotechnology Companies End-Use, CROs End-Use and Medical Device Firms End-Use - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 120: South Korea Historic Review for Clinical Trials Matching Software by End-Use - Pharmaceutical & Biotechnology Companies End-Use, CROs End-Use and Medical Device Firms End-Use Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 121: South Korea 15-Year Perspective for Clinical Trials Matching Software by End-Use - Percentage Breakdown of Value Sales for Pharmaceutical & Biotechnology Companies End-Use, CROs End-Use and Medical Device Firms End-Use for the Years 2015, 2025 & 2030
  • REST OF ASIA-PACIFIC
    • TABLE 122: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Clinical Trials Matching Software by Deployment - Web & Cloud-based Deployment and On-Premise Deployment - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 123: Rest of Asia-Pacific Historic Review for Clinical Trials Matching Software by Deployment - Web & Cloud-based Deployment and On-Premise Deployment Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 124: Rest of Asia-Pacific 15-Year Perspective for Clinical Trials Matching Software by Deployment - Percentage Breakdown of Value Sales for Web & Cloud-based Deployment and On-Premise Deployment for the Years 2015, 2025 & 2030
    • TABLE 125: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Clinical Trials Matching Software by End-Use - Pharmaceutical & Biotechnology Companies End-Use, CROs End-Use and Medical Device Firms End-Use - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 126: Rest of Asia-Pacific Historic Review for Clinical Trials Matching Software by End-Use - Pharmaceutical & Biotechnology Companies End-Use, CROs End-Use and Medical Device Firms End-Use Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 127: Rest of Asia-Pacific 15-Year Perspective for Clinical Trials Matching Software by End-Use - Percentage Breakdown of Value Sales for Pharmaceutical & Biotechnology Companies End-Use, CROs End-Use and Medical Device Firms End-Use for the Years 2015, 2025 & 2030
  • LATIN AMERICA
    • Clinical Trials Matching Software Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2025 (E)
    • TABLE 128: Latin America Recent Past, Current & Future Analysis for Clinical Trials Matching Software by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
    • TABLE 129: Latin America Historic Review for Clinical Trials Matching Software by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 130: Latin America 15-Year Perspective for Clinical Trials Matching Software by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2015, 2025 & 2030
    • TABLE 131: Latin America Recent Past, Current & Future Analysis for Clinical Trials Matching Software by Deployment - Web & Cloud-based Deployment and On-Premise Deployment - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 132: Latin America Historic Review for Clinical Trials Matching Software by Deployment - Web & Cloud-based Deployment and On-Premise Deployment Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 133: Latin America 15-Year Perspective for Clinical Trials Matching Software by Deployment - Percentage Breakdown of Value Sales for Web & Cloud-based Deployment and On-Premise Deployment for the Years 2015, 2025 & 2030
    • TABLE 134: Latin America Recent Past, Current & Future Analysis for Clinical Trials Matching Software by End-Use - Pharmaceutical & Biotechnology Companies End-Use, CROs End-Use and Medical Device Firms End-Use - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 135: Latin America Historic Review for Clinical Trials Matching Software by End-Use - Pharmaceutical & Biotechnology Companies End-Use, CROs End-Use and Medical Device Firms End-Use Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 136: Latin America 15-Year Perspective for Clinical Trials Matching Software by End-Use - Percentage Breakdown of Value Sales for Pharmaceutical & Biotechnology Companies End-Use, CROs End-Use and Medical Device Firms End-Use for the Years 2015, 2025 & 2030
  • ARGENTINA
    • TABLE 137: Argentina Recent Past, Current & Future Analysis for Clinical Trials Matching Software by Deployment - Web & Cloud-based Deployment and On-Premise Deployment - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 138: Argentina Historic Review for Clinical Trials Matching Software by Deployment - Web & Cloud-based Deployment and On-Premise Deployment Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 139: Argentina 15-Year Perspective for Clinical Trials Matching Software by Deployment - Percentage Breakdown of Value Sales for Web & Cloud-based Deployment and On-Premise Deployment for the Years 2015, 2025 & 2030
    • TABLE 140: Argentina Recent Past, Current & Future Analysis for Clinical Trials Matching Software by End-Use - Pharmaceutical & Biotechnology Companies End-Use, CROs End-Use and Medical Device Firms End-Use - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 141: Argentina Historic Review for Clinical Trials Matching Software by End-Use - Pharmaceutical & Biotechnology Companies End-Use, CROs End-Use and Medical Device Firms End-Use Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 142: Argentina 15-Year Perspective for Clinical Trials Matching Software by End-Use - Percentage Breakdown of Value Sales for Pharmaceutical & Biotechnology Companies End-Use, CROs End-Use and Medical Device Firms End-Use for the Years 2015, 2025 & 2030
  • BRAZIL
    • TABLE 143: Brazil Recent Past, Current & Future Analysis for Clinical Trials Matching Software by Deployment - Web & Cloud-based Deployment and On-Premise Deployment - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 144: Brazil Historic Review for Clinical Trials Matching Software by Deployment - Web & Cloud-based Deployment and On-Premise Deployment Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 145: Brazil 15-Year Perspective for Clinical Trials Matching Software by Deployment - Percentage Breakdown of Value Sales for Web & Cloud-based Deployment and On-Premise Deployment for the Years 2015, 2025 & 2030
    • TABLE 146: Brazil Recent Past, Current & Future Analysis for Clinical Trials Matching Software by End-Use - Pharmaceutical & Biotechnology Companies End-Use, CROs End-Use and Medical Device Firms End-Use - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 147: Brazil Historic Review for Clinical Trials Matching Software by End-Use - Pharmaceutical & Biotechnology Companies End-Use, CROs End-Use and Medical Device Firms End-Use Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 148: Brazil 15-Year Perspective for Clinical Trials Matching Software by End-Use - Percentage Breakdown of Value Sales for Pharmaceutical & Biotechnology Companies End-Use, CROs End-Use and Medical Device Firms End-Use for the Years 2015, 2025 & 2030
  • MEXICO
    • TABLE 149: Mexico Recent Past, Current & Future Analysis for Clinical Trials Matching Software by Deployment - Web & Cloud-based Deployment and On-Premise Deployment - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 150: Mexico Historic Review for Clinical Trials Matching Software by Deployment - Web & Cloud-based Deployment and On-Premise Deployment Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 151: Mexico 15-Year Perspective for Clinical Trials Matching Software by Deployment - Percentage Breakdown of Value Sales for Web & Cloud-based Deployment and On-Premise Deployment for the Years 2015, 2025 & 2030
    • TABLE 152: Mexico Recent Past, Current & Future Analysis for Clinical Trials Matching Software by End-Use - Pharmaceutical & Biotechnology Companies End-Use, CROs End-Use and Medical Device Firms End-Use - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 153: Mexico Historic Review for Clinical Trials Matching Software by End-Use - Pharmaceutical & Biotechnology Companies End-Use, CROs End-Use and Medical Device Firms End-Use Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 154: Mexico 15-Year Perspective for Clinical Trials Matching Software by End-Use - Percentage Breakdown of Value Sales for Pharmaceutical & Biotechnology Companies End-Use, CROs End-Use and Medical Device Firms End-Use for the Years 2015, 2025 & 2030
  • REST OF LATIN AMERICA
    • TABLE 155: Rest of Latin America Recent Past, Current & Future Analysis for Clinical Trials Matching Software by Deployment - Web & Cloud-based Deployment and On-Premise Deployment - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 156: Rest of Latin America Historic Review for Clinical Trials Matching Software by Deployment - Web & Cloud-based Deployment and On-Premise Deployment Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 157: Rest of Latin America 15-Year Perspective for Clinical Trials Matching Software by Deployment - Percentage Breakdown of Value Sales for Web & Cloud-based Deployment and On-Premise Deployment for the Years 2015, 2025 & 2030
    • TABLE 158: Rest of Latin America Recent Past, Current & Future Analysis for Clinical Trials Matching Software by End-Use - Pharmaceutical & Biotechnology Companies End-Use, CROs End-Use and Medical Device Firms End-Use - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 159: Rest of Latin America Historic Review for Clinical Trials Matching Software by End-Use - Pharmaceutical & Biotechnology Companies End-Use, CROs End-Use and Medical Device Firms End-Use Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 160: Rest of Latin America 15-Year Perspective for Clinical Trials Matching Software by End-Use - Percentage Breakdown of Value Sales for Pharmaceutical & Biotechnology Companies End-Use, CROs End-Use and Medical Device Firms End-Use for the Years 2015, 2025 & 2030
  • MIDDLE EAST
    • Clinical Trials Matching Software Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2025 (E)
    • TABLE 161: Middle East Recent Past, Current & Future Analysis for Clinical Trials Matching Software by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
    • TABLE 162: Middle East Historic Review for Clinical Trials Matching Software by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 163: Middle East 15-Year Perspective for Clinical Trials Matching Software by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2015, 2025 & 2030
    • TABLE 164: Middle East Recent Past, Current & Future Analysis for Clinical Trials Matching Software by Deployment - Web & Cloud-based Deployment and On-Premise Deployment - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 165: Middle East Historic Review for Clinical Trials Matching Software by Deployment - Web & Cloud-based Deployment and On-Premise Deployment Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 166: Middle East 15-Year Perspective for Clinical Trials Matching Software by Deployment - Percentage Breakdown of Value Sales for Web & Cloud-based Deployment and On-Premise Deployment for the Years 2015, 2025 & 2030
    • TABLE 167: Middle East Recent Past, Current & Future Analysis for Clinical Trials Matching Software by End-Use - Pharmaceutical & Biotechnology Companies End-Use, CROs End-Use and Medical Device Firms End-Use - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 168: Middle East Historic Review for Clinical Trials Matching Software by End-Use - Pharmaceutical & Biotechnology Companies End-Use, CROs End-Use and Medical Device Firms End-Use Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 169: Middle East 15-Year Perspective for Clinical Trials Matching Software by End-Use - Percentage Breakdown of Value Sales for Pharmaceutical & Biotechnology Companies End-Use, CROs End-Use and Medical Device Firms End-Use for the Years 2015, 2025 & 2030
  • IRAN
    • TABLE 170: Iran Recent Past, Current & Future Analysis for Clinical Trials Matching Software by Deployment - Web & Cloud-based Deployment and On-Premise Deployment - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 171: Iran Historic Review for Clinical Trials Matching Software by Deployment - Web & Cloud-based Deployment and On-Premise Deployment Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 172: Iran 15-Year Perspective for Clinical Trials Matching Software by Deployment - Percentage Breakdown of Value Sales for Web & Cloud-based Deployment and On-Premise Deployment for the Years 2015, 2025 & 2030
    • TABLE 173: Iran Recent Past, Current & Future Analysis for Clinical Trials Matching Software by End-Use - Pharmaceutical & Biotechnology Companies End-Use, CROs End-Use and Medical Device Firms End-Use - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 174: Iran Historic Review for Clinical Trials Matching Software by End-Use - Pharmaceutical & Biotechnology Companies End-Use, CROs End-Use and Medical Device Firms End-Use Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 175: Iran 15-Year Perspective for Clinical Trials Matching Software by End-Use - Percentage Breakdown of Value Sales for Pharmaceutical & Biotechnology Companies End-Use, CROs End-Use and Medical Device Firms End-Use for the Years 2015, 2025 & 2030
  • ISRAEL
    • TABLE 176: Israel Recent Past, Current & Future Analysis for Clinical Trials Matching Software by Deployment - Web & Cloud-based Deployment and On-Premise Deployment - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 177: Israel Historic Review for Clinical Trials Matching Software by Deployment - Web & Cloud-based Deployment and On-Premise Deployment Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 178: Israel 15-Year Perspective for Clinical Trials Matching Software by Deployment - Percentage Breakdown of Value Sales for Web & Cloud-based Deployment and On-Premise Deployment for the Years 2015, 2025 & 2030
    • TABLE 179: Israel Recent Past, Current & Future Analysis for Clinical Trials Matching Software by End-Use - Pharmaceutical & Biotechnology Companies End-Use, CROs End-Use and Medical Device Firms End-Use - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 180: Israel Historic Review for Clinical Trials Matching Software by End-Use - Pharmaceutical & Biotechnology Companies End-Use, CROs End-Use and Medical Device Firms End-Use Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 181: Israel 15-Year Perspective for Clinical Trials Matching Software by End-Use - Percentage Breakdown of Value Sales for Pharmaceutical & Biotechnology Companies End-Use, CROs End-Use and Medical Device Firms End-Use for the Years 2015, 2025 & 2030
  • SAUDI ARABIA
    • TABLE 182: Saudi Arabia Recent Past, Current & Future Analysis for Clinical Trials Matching Software by Deployment - Web & Cloud-based Deployment and On-Premise Deployment - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 183: Saudi Arabia Historic Review for Clinical Trials Matching Software by Deployment - Web & Cloud-based Deployment and On-Premise Deployment Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 184: Saudi Arabia 15-Year Perspective for Clinical Trials Matching Software by Deployment - Percentage Breakdown of Value Sales for Web & Cloud-based Deployment and On-Premise Deployment for the Years 2015, 2025 & 2030
    • TABLE 185: Saudi Arabia Recent Past, Current & Future Analysis for Clinical Trials Matching Software by End-Use - Pharmaceutical & Biotechnology Companies End-Use, CROs End-Use and Medical Device Firms End-Use - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 186: Saudi Arabia Historic Review for Clinical Trials Matching Software by End-Use - Pharmaceutical & Biotechnology Companies End-Use, CROs End-Use and Medical Device Firms End-Use Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 187: Saudi Arabia 15-Year Perspective for Clinical Trials Matching Software by End-Use - Percentage Breakdown of Value Sales for Pharmaceutical & Biotechnology Companies End-Use, CROs End-Use and Medical Device Firms End-Use for the Years 2015, 2025 & 2030
  • UNITED ARAB EMIRATES
    • TABLE 188: UAE Recent Past, Current & Future Analysis for Clinical Trials Matching Software by Deployment - Web & Cloud-based Deployment and On-Premise Deployment - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 189: UAE Historic Review for Clinical Trials Matching Software by Deployment - Web & Cloud-based Deployment and On-Premise Deployment Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 190: UAE 15-Year Perspective for Clinical Trials Matching Software by Deployment - Percentage Breakdown of Value Sales for Web & Cloud-based Deployment and On-Premise Deployment for the Years 2015, 2025 & 2030
    • TABLE 191: UAE Recent Past, Current & Future Analysis for Clinical Trials Matching Software by End-Use - Pharmaceutical & Biotechnology Companies End-Use, CROs End-Use and Medical Device Firms End-Use - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 192: UAE Historic Review for Clinical Trials Matching Software by End-Use - Pharmaceutical & Biotechnology Companies End-Use, CROs End-Use and Medical Device Firms End-Use Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 193: UAE 15-Year Perspective for Clinical Trials Matching Software by End-Use - Percentage Breakdown of Value Sales for Pharmaceutical & Biotechnology Companies End-Use, CROs End-Use and Medical Device Firms End-Use for the Years 2015, 2025 & 2030
  • REST OF MIDDLE EAST
    • TABLE 194: Rest of Middle East Recent Past, Current & Future Analysis for Clinical Trials Matching Software by Deployment - Web & Cloud-based Deployment and On-Premise Deployment - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 195: Rest of Middle East Historic Review for Clinical Trials Matching Software by Deployment - Web & Cloud-based Deployment and On-Premise Deployment Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 196: Rest of Middle East 15-Year Perspective for Clinical Trials Matching Software by Deployment - Percentage Breakdown of Value Sales for Web & Cloud-based Deployment and On-Premise Deployment for the Years 2015, 2025 & 2030
    • TABLE 197: Rest of Middle East Recent Past, Current & Future Analysis for Clinical Trials Matching Software by End-Use - Pharmaceutical & Biotechnology Companies End-Use, CROs End-Use and Medical Device Firms End-Use - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 198: Rest of Middle East Historic Review for Clinical Trials Matching Software by End-Use - Pharmaceutical & Biotechnology Companies End-Use, CROs End-Use and Medical Device Firms End-Use Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 199: Rest of Middle East 15-Year Perspective for Clinical Trials Matching Software by End-Use - Percentage Breakdown of Value Sales for Pharmaceutical & Biotechnology Companies End-Use, CROs End-Use and Medical Device Firms End-Use for the Years 2015, 2025 & 2030
  • AFRICA
    • Clinical Trials Matching Software Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2025 (E)
    • TABLE 200: Africa Recent Past, Current & Future Analysis for Clinical Trials Matching Software by Deployment - Web & Cloud-based Deployment and On-Premise Deployment - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 201: Africa Historic Review for Clinical Trials Matching Software by Deployment - Web & Cloud-based Deployment and On-Premise Deployment Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 202: Africa 15-Year Perspective for Clinical Trials Matching Software by Deployment - Percentage Breakdown of Value Sales for Web & Cloud-based Deployment and On-Premise Deployment for the Years 2015, 2025 & 2030
    • TABLE 203: Africa Recent Past, Current & Future Analysis for Clinical Trials Matching Software by End-Use - Pharmaceutical & Biotechnology Companies End-Use, CROs End-Use and Medical Device Firms End-Use - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 204: Africa Historic Review for Clinical Trials Matching Software by End-Use - Pharmaceutical & Biotechnology Companies End-Use, CROs End-Use and Medical Device Firms End-Use Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 205: Africa 15-Year Perspective for Clinical Trials Matching Software by End-Use - Percentage Breakdown of Value Sales for Pharmaceutical & Biotechnology Companies End-Use, CROs End-Use and Medical Device Firms End-Use for the Years 2015, 2025 & 2030

IV. COMPETITION

샘플 요청 목록
0 건의 상품을 선택 중
목록 보기
전체삭제